A Phase 1b Study Evaluating the Safety and Efficacy of AMG 757 in Combination with AMG 404 in Subjects with Small Cell Lung Cancer (SCLC)
For more information about the trial above please contact the study team:
Principal Investigator, Mariam Alexander, at email@example.com.
Study Coordinator, Taryn Wheeler, at firstname.lastname@example.org.
Trial opened at the following institutions: Medical University of South Carolina